Skip to main content
Log in

Evaluation of serological tests for diagnosis of Chlamydophila pneumoniae pneumonia in patients with nursing and healthcare-associated pneumonia

  • Original Article
  • Published:
Journal of Infection and Chemotherapy

Abstract

Nursing and healthcare-associated pneumonia (NHCAP) is a new category that is distinct from community-acquired pneumonia that has been documented in the 2011 Japanese Respiratory Society (JRS) guidelines. We aimed to evaluate an ELNAS Plate test for detecting anti-Chlamydophila pneumoniae-specific immunoglobulin M (IgM) antibodies in patients with NHCAP, by comparing the results of the ELNAS test with those of the Hitazyme enzyme-linked immunosorbent assay (Hitazyme-ELISA) and those of immunoblotting and microimmunofluorescence (MIF) tests. During the study period, we enrolled 739 patients with pneumonia in a university hospital and 812 patients with pneumonia in a community hospital; of these, 250 (34 %) and 349 (43 %), respectively, were classified as having NHCAP. C. pneumoniae pneumonia was detected in five cases by the MIF test and ELNAS test. All five cases demonstrated significant IgG antibody seroconversion, while one case was IgM-positive. Sixty-seven of the total of 599 patients (11 %) were C. pneumoniae IgM-positive on the Hitazyme-ELISA. One of the IgM-positive cases was confirmed by other methods and was shown to be a true positive. In the remaining cases, however, three other tests–the ELNAS test, the MIF test, and immunoblotting analysis–did not reveal any positive cases. The ELNAS, Hitazyme-ELISA, and MIF tests did not detect any significant increases in IgG or IgA antibody titers between paired sera. The results of the newly available ELNAS test for detecting anti-C. pneumoniae-specific IgM antibody correlated well with the results of the other established serological tests. To increase the diagnostic rate in patients with NHCAP, physicians should measure IgG antibody rather than IgM antibody using paired sera.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev. 1995;8:451–61.

    PubMed  CAS  Google Scholar 

  2. Troy CJ, Peeling RW, Ellis AG, Hockin JC, Bennett DA, Murphy MR, et al. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA. 1997;277:1214–8.

    Article  PubMed  CAS  Google Scholar 

  3. Miyashita N, Ouchi K, Shoji H, Obase Y, Fukuda M, Yoshida K, et al. Outbreak of Chlamydia pneumoniae infection in long-term care facilities and an affiliated hospital. J Med Microbiol. 2005;54:1243–7.

    Article  PubMed  Google Scholar 

  4. Nakashima K, Tanaka T, Kramer MH, Takahashi H, Ohyama T, Kishimoto T, et al. Outbreak of Chlamydia pneumoniae infection in a Japanese nursing home, 1999–2000. Infect Control Hosp Epidemiol. 2006;27:1171–7.

    Article  PubMed  Google Scholar 

  5. Maruyama T, Niederman MS, Kobayashi T, Kobayashi H, Takagi T, D’Alessandro-Gabazza CN, et al. A prospective comparison of nursing home-acquired pneumonia in non-intubated elderly. Respir Med. 2008;102:1287–95.

    Article  PubMed  CAS  Google Scholar 

  6. Maruyama T, Gabazza EC, Morser J, Takagi T, D’Alessandro-Gabazza C, Hirohata S, et al. Community-acquired pneumonia and nursing home-acquired pneumonia in the very elderly patients. Respir Med. 2010;104:584–92.

    Article  PubMed  Google Scholar 

  7. The Committee for the Japanese Respiratory Society guidelines in management of nursing and healthcare-associated pneumonia. The Japanese Respiratory Society guideline for the management of nursing and healthcare-associated pneumonia. In: Kohno S, Seki M, Watabnabe A, et al, editors. Tokyo: The Japanese Respiratory Society; 2011, pp 1–39 (in Japanese).

  8. Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis. 2001;33:492–503.

    Article  PubMed  CAS  Google Scholar 

  9. Kishimoto T, Ando S, Numazaki K, Ouchi K, Yamazaki T, Nakahama C. Assay of Chlamydia pneumoniae- specific IgM antibodies by ELISA method—reduction of non-specific reaction and resetting of serological criteria by measuring IgM antibodies. Jpn J Infect Dis. 2009;62:260–4.

    PubMed  Google Scholar 

  10. Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Kobashi Y, Oka M. Evaluation of false-positive reaction with ELISA for the detection of Chlamydophila pneumoniae-specific IgM antibody in adults. Jpn J Infect Dis. 2010;63:150–1.

    PubMed  CAS  Google Scholar 

  11. Miyashita N, Ouchi K, Kawasaki K, Komura H, Kawai Y, Tsumura N, et al. Comparison of serological tests for detection of immunoglobulin M antibodies to Chlamydophila pneumoniae. Respirology. 2008;13:427–31.

    Article  PubMed  Google Scholar 

  12. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27–72.

    Article  PubMed  CAS  Google Scholar 

  13. Persson K, Boman J. Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae. Clin Diagn Lab Immunol. 2000;7:739–44.

    PubMed  CAS  Google Scholar 

  14. Kishimoto T, Matsushima T, Morikawa T, Kawagoe K. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 3. Setting of serological criteria. Kansenshogaku Zasshi. 1999;73:457–66. (in Japanese).

    Google Scholar 

  15. Wang SP. The microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretation. J Infect Dis. 2000;181:S421–5.

    Article  PubMed  CAS  Google Scholar 

  16. Miyashita N, Matsumoto A. Establishment of a particle-counting method for purified elementary bodies of Chlamydiae and evaluation of sensitivities of IDEIA Chlamydia kit and DNA probe by using the purified elementary bodies. J Clin Microbiol. 1992;30:2911–6.

    PubMed  CAS  Google Scholar 

  17. Miyashita N, Matsumoto A, Kubota Y, Nakajima M, Niki Y, Matsushima T. Continuous isolation and characterization of Chlamydia pneumoniae from a patient with diffuse panbronchiolitis. Microbiol Immunol. 1996;40:547–52.

    PubMed  CAS  Google Scholar 

  18. Persson K, Haidl S. Evaluation of commercial test for antibodies to the chlamydial lipopolysaccharide (Medac) for serodiagnosis of acute infections by Chlamydia pneumoniae (TWAR) and Chlamydia psittaci. APMIS. 2000;108:131–8.

    Article  PubMed  CAS  Google Scholar 

  19. American Thoracic Society/Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416.

    Article  Google Scholar 

  20. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother. 2007;51:3568–73.

    Article  PubMed  CAS  Google Scholar 

  21. Verkooyen RP, Hazenberg MA, Van Haaren GH, Van Dean B, Snijder RJ, Van Helden HP, et al. Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor. J Clin Microbiol. 1992;30:1287–90.

    PubMed  CAS  Google Scholar 

  22. Miyashita N, Obase Y, Fukuda M, Shouji H, Mouri K, Yagi S, et al. Evaluation of serological tests detecting Chlamydophila pneumoniae-specific immunoglobulin M antibody. Intern Med. 2006;45:1127–31.

    Article  PubMed  Google Scholar 

  23. Carratala J, Mykietiuk A, Fernandez-Sabe N, Suarez C, Dorca J, Verdaguer R, et al. Health care-associated pneumonia requiring admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med. 2007;167:1393–9.

    Article  PubMed  Google Scholar 

  24. Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Hashimoto N, et al. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest. 2009;135:633–40.

    Article  PubMed  Google Scholar 

  25. Umeki K, Tokimatsu I, Yasuda C, Iwata A, Yoshioka D, Ishii H, et al. Clinical features of healthcare-associated pneumonia (HCAP) in Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia. Respirology. 2011;16:856–61.

    Article  PubMed  Google Scholar 

  26. Watanabe M, Kato K, Takeda K, Konishi T, Kurai J, Tatsukawa T, et al. Difference of health-care associated pneumonia between large hospitals and small hospitals in Japan. J Med Invest. 2011;58:67–74.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by MEXT KAKENHI (19591190 and 21591304) and Project Research Grants from Kawasaki Medical School (13-401, 14-402, 15-405A, 16-405M, 17-402M, 18-401, 19-402M, 20-4030).

Conflict of interest

The authors have no conflicting interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naoyuki Miyashita.

About this article

Cite this article

Miyashita, N., Akaike, H., Teranishi, H. et al. Evaluation of serological tests for diagnosis of Chlamydophila pneumoniae pneumonia in patients with nursing and healthcare-associated pneumonia. J Infect Chemother 19, 249–255 (2013). https://doi.org/10.1007/s10156-012-0491-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-012-0491-7

Keywords

Navigation